Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;31(1):18-24.
doi: 10.1111/vec.13011. Epub 2020 Oct 29.

Evaluation of point-of-care coagulation tests as alternatives to anti-Xa activity for monitoring the anticoagulant effects of rivaroxaban in healthy dogs

Alex M Lynch  1 , Laura K Ruterbories  1 , Emily H Griffith  2 , Rita M Hanel  3 , Alyssa P Stablein  4 , Marjory B Brooks  4
Affiliations

Evaluation of point-of-care coagulation tests as alternatives to anti-Xa activity for monitoring the anticoagulant effects of rivaroxaban in healthy dogs

Alex M Lynch et al. J Vet Emerg Crit Care (San Antonio). 2021 Jan.

Abstract

Objective: To evaluate a panel of coagulation assays for their potential utility in rivaroxaban monitoring as alternatives to the rivaroxaban-specific anti-Xa activity (RIVA).

Design: Prospective experimental study.

Setting: University research laboratory.

Animals: Five healthy neutered male Beagles.

Interventions: Dogs were administered a median dose of 1.8 mg/kg rivaroxaban (range, 1.6-1.8 mg/kg) orally once daily for 2 consecutive days as part of a pharmacodynamic study. Blood was collected from a preplaced jugular catheter at time points relative to their rivaroxaban administration (0, 2, 4, 8, 24, 36, and 48 h) for measurement of RIVA, prothrombin time (PT), activated partial thromboplastin time, RapidTEG, and thrombin generation variables.

Measurements and main results: One hundred forty data points were available for analysis. There was poor correlation between RIVA and RapidTEG variables: R time (R) (min) (r = 0.554, P < 0.0001), K time (K) (min) (r = -0.204, P = 0.016), alpha angle (degrees) (r = 0.152, P = 0.073), Maximum amplitude (MA) (mm) (r = 0.106, P = 0.215), and G value (G) (dynes/s) (r = 0.108, P = 0.205). A good correlation was noted between thrombin generation variables and RIVA: lag time (min) (r = 0.827, P < 0.0001), peak (nM) (r = -0.752, P < 0.0001), and endogenous thrombin potential (nM·min) (r = -0.762, P < 0.0001). There was an excellent correlation between PT and RIVA (r = 0.915, P < 0.0001) and a good correlation between activated partial thromboplastin time and RIVA (r = 0.772, P < 0 .0001).

Conclusions: Of all the coagulation tests investigated, the PT correlated best with RIVA. There is potential for PT being a convenient second-line monitoring option in dogs receiving rivaroxaban, but further work is necessary to validate other PT assays. Thromboelastography performed with strong activators correlated poorly with anti-Xa activity.

Keywords: anticoagulant; antithrombotic; canine direct oral anticoagulants; thromboembolism.

PubMed Disclaimer

References

REFERENCES

    1. Carr A, Panciera D, Kidd L. Prognostic factors for mortality and thromboembolism in canine immune-mediated hemolytic anemia: a retrospective study of 72 dogs. J Vet Intern Med. 2002;16(5):504-509.
    1. Respess M, O'Toole TE, Taeymans O, et al. Portal vein thrombosis in 33 dogs: 1998-2011. J Vet Intern Med. 2012;26(2):230-237.
    1. Winter RL, Budke CM. Multicenter evaluation of signalment and comorbid conditions associated with aortic thrombotic disease in dogs. J Am Vet Med Assoc. 2017;251(4):438-442.
    1. Marschner CB, Kristensen AT, Rozanski EA, et al. Diagnosis of canine pulmonary thromboembolism by computed tomography and mathematical modeling using haemostatic and inflammatory variables. Vet J. 2017;229:6-12.
    1. Wendelburg KM, O'Toole TE, MCobb E, et al. Risk factors for perioperative death in dogs undergoing splenectomy for splenic masses: 539 cases (2001-2012). J Am Vet Med Assoc. 2014;245(12):1382-1390.

MeSH terms

LinkOut - more resources